Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 060851/0636 | |
| Pages: | 9 |
| | Recorded: | 08/22/2022 | | |
| Attorney Dkt #: | 3338.063000A/E/F/G/H |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
5
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/18/2019
|
Application #:
|
16230657
|
Filing Dt:
|
12/21/2018
|
|
Publication #:
|
|
Pub Dt:
|
04/18/2019
| | | | |
|
Title:
|
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/31/2020
|
Application #:
|
16231211
|
Filing Dt:
|
12/21/2018
|
|
Publication #:
|
|
Pub Dt:
|
04/18/2019
| | | | |
|
Title:
|
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/10/2020
|
Application #:
|
16248215
|
Filing Dt:
|
01/15/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/23/2019
| | | | |
|
Title:
|
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/03/2020
|
Application #:
|
16248222
|
Filing Dt:
|
01/15/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/09/2019
| | | | |
|
Title:
|
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16827580
|
Filing Dt:
|
03/23/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/01/2020
| | | | |
|
Title:
|
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
|
|
|
Assignee
|
|
|
|
|
| RT. 206 & PROVINCE LINE ROAD |
| PRINCETON, NEW JERSEY 08543 |
|
|
Correspondence name and address
|
| |
STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
|
| |
1100 NEW YORK AVENUE, N.W.
|
| |
WASHINGTON, DC 20005
|
Search Results as of:
04/27/2024 12:22 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
